These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 16377282

  • 1. Effects of morning versus evening intake of atorvastatin on major cardiac event and restenosis rates in patients undergoing first elective percutaneous coronary intervention.
    Ozaydin M, Dede O, Dogan A, Aslan SM, Altinbas A, Ozturk M, Varol E, Turker Y.
    Am J Cardiol; 2006 Jan 01; 97(1):44-7. PubMed ID: 16377282
    [Abstract] [Full Text] [Related]

  • 2. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G, ARMYDA Investigators.
    Circulation; 2004 Aug 10; 110(6):674-8. PubMed ID: 15277322
    [Abstract] [Full Text] [Related]

  • 3. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J, Zemánek D, Hájek P, Malý M, Adlová R, Martinkovicová L, Tesar D.
    Am J Cardiol; 2009 Sep 01; 104(5):630-3. PubMed ID: 19699335
    [Abstract] [Full Text] [Related]

  • 4. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
    Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, Montinaro A, Di Sciascio G.
    J Am Coll Cardiol; 2007 Mar 27; 49(12):1272-8. PubMed ID: 17394957
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention.
    Veselka J, Zemánek D, Hájek P, Malý M, Adlová R, Martinkovičová L, Tomašov P, Tesař D.
    Am J Cardiol; 2011 May 01; 107(9):1295-9. PubMed ID: 21349484
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial.
    Leone AM, Rutella S, Giannico MB, Perfetti M, Zaccone V, Brugaletta S, Garramone B, Niccoli G, Porto I, Liuzzo G, Biasucci LM, Bellesi S, Galiuto L, Leone G, Rebuzzi AG, Crea F.
    Int J Cardiol; 2008 Nov 28; 130(3):457-62. PubMed ID: 18667247
    [Abstract] [Full Text] [Related]

  • 9. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy.
    Miedema MD, Conover CA, MacDonald H, Harrington SC, Oberg D, Wilson D, Henry TD, Schwartz RS.
    Am J Cardiol; 2008 Jan 01; 101(1):35-9. PubMed ID: 18157962
    [Abstract] [Full Text] [Related]

  • 10. Effects of loading dose of atorvastatin before percutaneous coronary intervention on periprocedural myocardial injury.
    Yu XL, Zhang HJ, Ren SD, Geng J, Wu TT, Chen WQ, Ji XP, Zhong L, Ge ZM.
    Coron Artery Dis; 2011 Mar 01; 22(1):87-91. PubMed ID: 21169815
    [Abstract] [Full Text] [Related]

  • 11. Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
    Patti G, Chello M, Gatto L, Alfano G, Miglionico M, Covino E, Di Sciascio G.
    J Cardiovasc Med (Hagerstown); 2010 Nov 01; 11(11):795-800. PubMed ID: 20613550
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
    Patti G, Chello M, Pasceri V, Colonna D, Nusca A, Miglionico M, D'Ambrosio A, Covino E, Di Sciascio G.
    J Am Coll Cardiol; 2006 Oct 17; 48(8):1560-6. PubMed ID: 17045888
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.
    Kumar A, Cannon CP.
    J Interv Cardiol; 2007 Dec 17; 20(6):447-57. PubMed ID: 18042049
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.